We are live on
!
Find out more
IBO
Impact BioMedical
20 hedge funds and large institutions have $2.23M invested in Impact BioMedical in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$559K | |
| 2 | +$298K | |
| 3 | +$117K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$15.1K |
| 5 |
GTAM
Global Trust Asset Management
West Palm Beach,
Florida
|
+$909 |
Top Sellers
| 1 | -$69.6K | |
| 2 | -$11.5K | |
| 3 | -$8.33K | |
| 4 |
Jane Street
New York
|
-$7.11K |
| 5 |
HF
HRT Financial
New York
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| – |
|
|||
27
Bank of America
Charlotte,
North Carolina
| – |
|
|||
|
SRCM
28
Signature Resources Capital Management
Newport Beach,
California
| – |
|
|||
29
Group One Trading
Chicago,
Illinois
| – |
|